TrademarkDir
RECIPHARM
LIVE

Serial Number

79089041

Owner

Recipharm AB (publ)

Attorney

Richard J. McKenna

Filing Date

Sep 23, 2010

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

RECIPHARM Trademark

Serial Number: 79089041 • Registration: 4061976

RECIPHARM is a trademark filed by Recipharm AB (publ) on September 23, 2010. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Recipharm AB (publ) (3 trademarks)

Box 603

Entity Type: 03

Trademark Details

Filing Date

September 23, 2010

Registration Date

November 29, 2011

Published for Opposition

September 13, 2011

Goods & Services

[ Pharmaceutical preparations, namely, antibacterial pharmaceuticals, anti-diabetic pharmaceuticals, balms for pharmaceutical purposes, cardiovascular pharmaceuticals, dermatological pharmaceutical products, digestives for pharmaceutical purposes, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders, ocular pharmaceuticals, pharmaceutical anti-allergic preparations and substances, pharmaceutical anti-allergic preparations and substances, anticoagulants, antidepressants, appetite suppressants, pharmaceutical preparations for use in chemotherapy, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations for the treatment of infectious diseases, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for wounds, pharmaceutical preparations for use in urology, pharmaceutical preparations for skin care, pharmaceutical preparations for the treatment of kidney diseases, pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders, and pharmaceutical preparations for the treatment of the thyroid gland ]

[ Medical research laboratory services; ] [ consultation services related to research in the field of development of surgical products; ] [ product development; development of medical products; and ] scientific and technological services and research and design relating thereto for medical purposes, namely, medical and scientific research in the fields of [ cancer treatment, cardiovascular treatment, treatment of infectious diseases, and ] treatment of a wide variety of major medical human disorders

Filing History

PARTIAL INVALIDATION PROCESSED BY THE IB
Mar 17, 2024 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 7, 2024 INPS
INVALIDATION PROCESSED
Feb 7, 2024 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 31, 2024 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 31, 2023 NA71
REGISTERED-SEC.71 ACCEPTED
May 31, 2023 71AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Apr 17, 2023 EROP
POST REGISTRATION ACTION MAILED - SEC.71
Nov 2, 2022 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 24, 2022 APRE
TEAS SECTION 71 RECEIVED
May 10, 2022 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Nov 29, 2020 REM4
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 6, 2020 ADCH
INTERNATIONAL REGISTRATION RENEWED
Oct 30, 2020 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Oct 12, 2018 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 5, 2018 INPS
INVALIDATION PROCESSED
Sep 5, 2018 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 17, 2018 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Dec 4, 2017 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Dec 4, 2017 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 1, 2017 APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 16, 2017 APRE
TEAS SECTION 71 & 15 RECEIVED
Nov 8, 2017 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 29, 2016 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 10, 2012 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 23, 2012 FICS
FINAL DISPOSITION PROCESSED
Jul 23, 2012 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 29, 2012 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 29, 2011 R.PR
NOTIFICATION PROCESSED BY IB
Nov 20, 2011 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 13, 2011 NPUB
PUBLISHED FOR OPPOSITION
Sep 13, 2011 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 24, 2011 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 24, 2011 OP2R
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 11, 2011 PREV
ASSIGNED TO LIE
Aug 11, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2011 TROA
REFUSAL PROCESSED BY IB
Jan 29, 2011 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 11, 2011 RFCS
REFUSAL PROCESSED BY MPU
Jan 11, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 10, 2011 RFCR
NON-FINAL ACTION WRITTEN
Jan 9, 2011 CNRT
ASSIGNED TO EXAMINER
Dec 31, 2010 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 23, 2010 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 19, 2010 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 18, 2010 REPR

Related Trademarks

More from this Owner

RECIPHARM PATHWAY TO CLINIC

RECIPHARM PATHWAY TO CLINIC

RECIPHARM PATHWAY TO CLINIC

RECIPHARM PATHWAY TO CLINIC

RECIPHARM PATHWAY TO CLINIC

RECIPHARM PATHWAY TO CLINIC

THYROSAFE

THYROSAFE

THYROSAFE

THYROSAFE